Key Developments: Henry Schein Inc (HSIC.O)
95.35USD
2:15pm EDT
$-0.03 (-0.03%)
$95.38
$95.52
$95.98
$95.22
143,159
366,928
$96.28
$71.97
Latest Key Developments (Source: Significant Developments)
Henry Schein Inc Reaffirms FY 2013 EPS Guidance
Henry Schein Inc reaffirmed its fiscal 2013 and expects diluted earnings per share (EPS) attributable to be $4.81 to $4.91, which represents growth of 8% to 11% compared with fiscal 2012 results excluding restructuring costs. This guidance excludes the one-time, non-cash charge of $0.03 per diluted share related to the refinancing of Butler Schein Animal Health debt. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $4.87 for fiscal 2013. Full Article
Henry Schein Inc Secures $300 Million Of Committed Financing
Henry Schein Inc announced that it has entered into a facility agreement of up to $300 million with The Bank of Tokyo-Mitsubishi UFJ, Ltd. based on the securitization of its accounts receivable. The facility is committed and has a maturity of three years. Henry Schein plans to use this new facility for working capital and general corporate purposes, including, but not limited to, capital expenditures, the repurchase of the Company's capital stock and permitted refinancing of existing debt, as well as for funding potential acquisitions. Full Article
Henry Schein Inc Reaffirms FY 2013 EPS Guidance
Henry Schein Inc reaffirmed its fiscal 2013 and expects diluted earnings per share (EPS) attributable to be $4.81 to $4.91, which represents growth of 8% to 11% compared with fiscal 2012 results excluding restructuring costs. This guidance excludes the one-time, non-cash charge of approximately $0.04 to $0.05 per diluted share related to the refinancing of Butler Schein Animal Health debt. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $4.85 for fiscal 2013. Full Article
Henry Schein Inc Completes Acquisition of C&M Vetlink
Henry Schein Inc announced that it has completed the acquisition of C&M Vetlink, distributor of animal health products in Ireland. All closing conditions have been met, including approval of the transaction by Ireland's Competition Authority and from C&M Vetlink shareholders. Financial terms were not disclosed. Full Article
Henry Schein Inc Issues FY 2012 Revenue Guidance In Line With Analysts' Estimates-Conference Call
Henry Schein Inc announced that in fiscal 2012, it will get closer to the $9 billion of sales. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $9 billion for fiscal 2012. Full Article
Henry Schein Inc Announces $300 Million Increase To Share Repurchase Plan
Henry Schein Inc announced that its Board of Directors has authorized the repurchase of up to $300 million of shares of the Company's common stock. This program is in addition to the $200 million repurchase program announced in April 2012, which as of today has approximately $57.5 million remaining authorized for future repurchases. Full Article
Henry Schein Inc Raises Low End Of Prior FY 2012 EPS Guidance To A Range In Line With Analysts' Estimates; Issues FY 2013 EPS Guidance Above Analysts' Estimates
Henry Schein Inc raised the low end of its fiscal 2012 financial guidance range. For fiscal 2012, the Company expects diluted EPS attributable to Henry Schein, Inc. to be $4.35 to $4.40, which represents growth of 10% to 11% compared with fiscal 2011 results and compares with previous guidance of $4.30 to $4.40. For fiscal 2013, the Company expects diluted EPS attributable to Henry Schein, Inc. to be $4.81 to $4.91. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $4.36 for fiscal 2012 and EPS of $4.79 for fiscal 2013. Full Article
Henry Schein Inc Acquires Majority Interest In Dental Software Company
Henry Schein Inc announced that is has acquired a majority interest in The Exan Group (Exan), a privately held dental software company with headquarters in Port Coquitlam, British Columbia, Canada. The remaining ownership interest will continue to be held primarily by Exan executive management. Through this transaction Henry Schein further expands its business with dental schools in the U.S. and Canada, as well as general practice dental offices primarily in Canada. Terms of the transaction were not disclosed. Full Article
LED Medical Diagnostics Inc Amends Relationship with Henry Schein, Inc.
LED Medical Diagnostics Inc announced the amendment of its distribution agreement with Henry Schein, Inc. The Company's VELscope Vx product will now be available directly through LED. Henry Schein, Inc. will continue to support VELscope Vx by supplying existing customers with VELscope consumables, and by continuing to service the large group practice client base. Full Article
Henry Schein Inc Announces New $500 Million Credit Facility
Henry Schein Inc announced the closing of a new $500 million revolving credit facility. This new facility, which matures in September 2017, replaces Henry Schein's current $400 million revolving facility, which was scheduled to mature in September 2013. J.P. Morgan Securities LLC served as Sole Bookrunner and Joint Lead Arranger for the new facility. HSBC Bank USA, National Association also served as Joint Lead Arranger. Henry Schein plans to use its credit facility for working capital and general corporate purposes, including, but not limited to, capital expenditures, the repurchase of the Company's capital stock and permitted refinancing of existing debt, as well as for funding potential acquisitions. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
